Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Teva Pharmaceuticals names former Sandoz exec to CEO post 

By Brian Buntz | November 21, 2022

TevaGenerics giant Teva Pharmaceuticals (NYSE:TEVA) has named Richard Francis, the CEO of gene therapy company Purespring Therapeutics, as its leader. Purespring Therapeutics is one of the first adeno-associated virus (AAV) gene therapy companies focused on kidney disease.

Francis is also the CEO of the cardiotherapy-focused firm Forcefield Therapeutics, and an operating partner for Syncona Investment Management Ltd.

Teva Pharmaceuticals’s current chief executive Kåre Schultz will retire on December 31, 2022.

Richard Francis

Richard Francis

Francis was the division head and CEO of Sandoz, a subsidiary of Novartis (NYSE:NVS), from 2014 to 2019. Before that, he worked at Biogen (Nasdaq:BIIB) for more than 12 years, eventually becoming the president and senior vice president of Biogen, U.S. At Biogen, he was responsible for the commercialization of the multiple sclerosis drug Tecfidera (dimethyl fumarate) in 2013. Sales of the drug reached $3.84 billion in 2020, but have fallen since following the introduction of Tecfidera generics.

Francis has also worked at Sanofi and Wyeth.

In all, Francis has more than 25 years of experience in the pharma industry.

Francis will assume the CEO role on January 1, 2023.

“I look forward to leveraging my background and years of pharmaceutical experience to build on Teva’s strong fundamentals and to write the next exciting chapter for Teva, focusing on building a solid pathway to deliver long-term growth,” Francis said in a news release.

In mid-day trading, TEVA shares were down about one point to $8.64.

Earlier this year, Teva Pharmaceuticals agreed that it would pay more than $4 billion to settle thousands of U.S. opioid lawsuits.

The company acquired Allergan’s generic business, which included opioids, in 2017.

In 2018, Teva moved its U.S. headquarters from Pennsylvania to Parsippany-Troy Hills, North Jersey.

In early November, a Boston federal jury ruled that Eli Lilly must pay Teva $176.5 million, concluding that Lilly’s migraine drug Emgality infringed three Teva patents.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE